BÜHLMANN presented a poster on Quantum Blue® Infliximab and Adalimumab using capillary blood at this year’s ECCO Congress in Copenhagen.
- info@buhlmannlabs.ch
- +41 61 487 12 12
News
We are pleased to announce that a new edition of our VOX BÜHLMANN is out now.
Two Quantum Blue® posters about fecal pancreatic elastase and infliximab and adalimumab trough level measurements from capillary blood were presented at the UEG Week 2022.
We are happy to share a customer success story from Dr. Giuliana Cangemi from the Gaslini Institute of the Pediatric Hospital in Genova explaining how they successfully introduced all four Quantum Blue® TDM assays into clinical routine.
Social Links